-
公开(公告)号:DK2928868T3
公开(公告)日:2017-10-23
申请号:DK13799544
申请日:2013-12-04
Applicant: HOFFMANN LA ROCHE
Inventor: BENDELS STEFANIE , GRETHER UWE , KIMBARA ATSUSHI , NETTEKOVEN MATTHIAS , ROEVER STEPHAN , ROGERS-EVANS MARK , SCHAFFTER ERNST , SCHULZ-GASCH TANJA
IPC: C07D213/81 , C07D401/04 , C07D401/06 , C07D401/14 , C07D405/12 , C07D405/14 , C07D413/06 , C07D413/14 , C07D417/06 , C07D471/10 , C07D487/08 , C07D491/04 , C07D491/08 , C07D491/10 , C07D495/10
-
公开(公告)号:AU2013354114B2
公开(公告)日:2018-02-15
申请号:AU2013354114
申请日:2013-12-04
Applicant: HOFFMANN LA ROCHE
Inventor: BENDELS STEFANIE , GRETHER UWE , KIMBARA ATSUSHI , NETTEKOVEN MATTHIAS , ROEVER STEPHAN , ROGERS EVANS MARK , SCHAFFTER ERNST , SCHULZ GASCH TANJA
IPC: C07D213/81 , C07D401/04 , C07D401/06 , C07D401/14 , C07D405/12 , C07D405/14 , C07D413/06 , C07D413/14 , C07D417/06 , C07D471/10 , C07D487/08 , C07D491/04 , C07D491/08 , C07D491/10 , C07D495/10
Abstract: The invention relates to CB2 agonists of formula (I) wherein R
-
公开(公告)号:CR20150204A
公开(公告)日:2015-05-18
申请号:CR20150204
申请日:2015-04-20
Applicant: HOFFMANN LA ROCHE
Inventor: BENDELS STEFANIE , GRETHER UWE , KIMBARA ATSUSHI , NETTEKOVEN MATTHIAS , ROEVER STEPHAN , ROGERS-EVANS MARK , SCHAFFTER ERNST , SCHULZ-GASCH TANJA
IPC: C07D213/81 , C07D401/04 , C07D401/14 , C07D405/12 , C07D405/14 , C07D413/06 , C07D413/14 , C07D471/10 , C07D491/08 , C07D491/10
Abstract: La invención se refiere a un compuesto de la fórmula (I): en la que de R1 a R4 tienen los significados definidos en la descripción y en las reivindicaciones. El compuesto de la fórmula (I) puede utilizarse como medicamento.
-
公开(公告)号:ES2643058T3
公开(公告)日:2017-11-21
申请号:ES13799544
申请日:2013-12-04
Applicant: HOFFMANN LA ROCHE
Inventor: BENDELS STEFANIE , GRETHER UWE , KIMBARA ATSUSHI , NETTEKOVEN MATTHIAS , ROEVER STEPHAN , ROGERS-EVANS MARK , SCHAFFTER ERNST , SCHULZ-GASCH TANJA
IPC: C07D213/81 , C07D401/04 , C07D401/06 , C07D401/14 , C07D405/12 , C07D405/14 , C07D413/06 , C07D413/14 , C07D417/06 , C07D471/10 , C07D487/08 , C07D491/04 , C07D491/08 , C07D491/10 , C07D495/10
-
公开(公告)号:HRP20171445T1
公开(公告)日:2017-11-03
申请号:HRP20171445
申请日:2017-09-26
Applicant: HOFFMANN LA ROCHE
Inventor: BENDELS STEFANIE , GRETHER UWE , KIMBARA ATSUSHI , NETTEKOVEN MATTHIAS , ROEVER STEPHAN , ROGERS-EVANS MARK , SCHAFFTER ERNST , SCHULZ-GASCH TANJA
IPC: C07D213/81 , C07D401/04 , C07D401/06 , C07D401/14 , C07D405/12 , C07D405/14 , C07D413/06 , C07D413/14 , C07D417/06 , C07D471/10 , C07D487/08 , C07D491/04 , C07D491/08 , C07D491/10 , C07D495/10
-
公开(公告)号:EA025841B1
公开(公告)日:2017-02-28
申请号:EA201590854
申请日:2013-12-04
Applicant: HOFFMANN LA ROCHE
Inventor: BENDELS STEFANIE , GRETHER UWE , KIMBARA ATSUSHI , NETTEKOVEN MATTHIAS , ROEVER STEPHAN , ROGERS-EVANS MARK , SCHAFFTER ERNST , SCHULZ-GASCH TANJA
IPC: C07D213/81 , C07D401/04 , C07D401/06 , C07D401/14 , C07D405/12 , C07D405/14 , C07D413/06 , C07D413/14 , C07D417/06 , C07D471/10 , C07D487/08 , C07D491/04 , C07D491/08 , C07D491/10 , C07D495/10
Abstract: Изобретениеотноситсяк агонистамСВ2 формулы (I), где R-Rопределены, какв описаниии вформулеизобретения. Соединениеформулы (I) можноиспользоватьв качествелекарства.
-
公开(公告)号:SG11201504122YA
公开(公告)日:2015-06-29
申请号:SG11201504122Y
申请日:2013-12-04
Applicant: HOFFMANN LA ROCHE
Inventor: BENDELS STEFANIE , GRETHER UWE , KIMBARA ATSUSHI , NETTEKOVEN MATTHIAS , ROEVER STEPHAN , ROGERS-EVANS MARK , SCHAFFTER ERNST , SCHULZ-GASCH TANJA
IPC: C07D213/81 , C07D401/04 , C07D401/06 , C07D401/14 , C07D405/12 , C07D405/14 , C07D413/06 , C07D413/14 , C07D417/06 , C07D471/10 , C07D487/08 , C07D491/04 , C07D491/08 , C07D491/10 , C07D495/10
Abstract: The invention relates to CB2 agonists of formula (I) wherein R1 to R4 are defined as in the description and in the claims. The compound of formula (I) can be used as a medicament.
-
公开(公告)号:RS56423B1
公开(公告)日:2018-01-31
申请号:RSP20171007
申请日:2013-12-04
Applicant: HOFFMANN LA ROCHE
Inventor: BENDELS STEFANIE , GRETHER UWE , KIMBARA ATSUSHI , NETTEKOVEN MATTHIAS , ROEVER STEPHAN , ROGERS-EVANS MARK , SCHAFFTER ERNST , SCHULZ-GASCH TANJA
IPC: C07D401/04 , C07D213/81 , C07D401/06 , C07D401/14 , C07D405/12 , C07D405/14 , C07D413/06 , C07D413/14 , C07D417/06 , C07D471/10 , C07D487/08 , C07D491/04 , C07D491/08 , C07D491/10 , C07D495/10
-
公开(公告)号:MA38218A1
公开(公告)日:2016-04-29
申请号:MA38218
申请日:2015-06-19
Applicant: HOFFMANN LA ROCHE
Inventor: GRETHER UWE , KIMBARA ATSUSHI , NETTEKOVEN MATTHIAS , ROEVER STEPHAN , ROGERS-EVANS MARK , SCHULZ-GASCH TANJA , BENDELS STEFANIE , SCHAFFTER ERNST
IPC: C07D213/81 , C07D401/04 , C07D401/06 , C07D401/14 , C07D405/12 , C07D405/14 , C07D413/06 , C07D413/14 , C07D417/06 , C07D471/10 , C07D487/08 , C07D491/04 , C07D491/08 , C07D491/10 , C07D495/10
Abstract: La présente invention concerne des agonistes de cb2 de formule (i) où r1 à r4 sont tels que définis dans la description et les revendications. Le composé de formule (i) peut être utilisé comme médicament.
-
公开(公告)号:ZA201502872B
公开(公告)日:2016-02-24
申请号:ZA201502872
申请日:2015-04-28
Applicant: HOFFMANN LA ROCHE
Inventor: ROEVER STEPHAN , NETTEKOVEN MATTHIAS , GRETHER UWE , SCHULZ-GASCH TANJA , SCHAFFTER ERNST , ROGERS-EVANS MARK , BENDELS STEFANIE , KIMBARA ATSUSHI
Abstract: The invention relates to CB2 agonists of formula (I) wherein R1 to R4 are defined as in the description and in the claims. The compound of formula (I) can be used as a medicament.
-
-
-
-
-
-
-
-
-